Exchange: NASDAQ·Updated 07:30 PM EDT

IART News

News
all
press releases
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for DirectionPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Stock Preachers News Commentary- Wall Street closed out the week split...
PR Newswire
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for DirectionPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Stock Preachers News Commentary- Wall Street closed out the week split...
PR Newswire
More News
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the WeekPR NewswireVANCOUVER, BC, Oct. 3, 2026VANCOUVER, BC, Oct. 3, 2026 /PRNewswire/ -- Stock Preachers News Commentary- Big...
PR Newswire
Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)
Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART) Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)PR NewswireNEW YORK, Oct. 2, 2026A $4.3...
PR Newswire
Integra LifeSciences Cuts FY26 Guidance Following Cincinnati Facility Flooding; Stock Tumbles 11.4%
(RTTNews) - Providing certain unaudited preliminary third quarter results on Friday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2026, based on revised assumptions regarding the expecte...
Nasdaq News: Markets
IART vs. PEN: Which Stock Is the Better Value Option?
IART vs. PEN: Which Stock Is the Better Value Option?
Zacks
Should You Continue to Hold IART Stock in Your Portfolio?
Integra sees steady Specialty Surgery demand and improving efficiency, but leverage and currency swings remain key challenges for Integra.
Zacks
IART or PEN: Which Is the Better Value Stock Right Now?
IART vs. PEN: Which Stock Is the Better Value Option?
Zacks
Here's Why Integra LifeSciences (IART) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks

Advertisement|Remove ads.